Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry
Company News Release
DIA 45th Annual Meeting, San Diego – June 22, 2009
In a new report, IDC Health Insights, an advisory services and market research firm focused on the healthcare and life science markets, ranked Oracle as the number one vendor for enterprise life sciences software applications.
The Life Science Software Top 10 identifies the 10 leading enterprise and specialty software vendors serving the sector based on enterprise life science software license revenue.
The report cites Oracle’s increased commitment and focus on life sciences for driving its leading share of the $2.95 billion that IDC Health Insights estimates is spent annually on software in the life sciences sector.
According to report, “Oracle easily topped the chart, with nearly $60 million more than the second-place SAP.”
The ranking is based solely on software license revenue derived from life sciences customers, and the study examined only enterprise solutions, which included: business intelligence/analytics, clinical software, customer relationship management (CRM), content management, revenue management/enterprise resource planning (ERP), human resources (HR), manufacturing, supply chain management, product lifecycle management (PLM), research and development (R&D) informatics and R&D discovery platforms.
“Oracle has a proven track record as a strategic provider of complete, open and integrated software applications to the life sciences sector,” said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences. “Oracle’s position as the number one software vendor in the life sciences sector underscores our commitment to helping customers accelerate insights for better health by enabling them to achieve greater operational efficiency and optimize performance.”
“Oracle’s fast-paced acquisition strategy, coupled with its increased commitment and focus on the life sciences via its new Health Sciences Global Business Unit has paid big dividends, which have helped to drive its success in the life science industry,” wrote Eric Newmark, Research Manager, IDC Health Insights, in the report.